イベルメクチンの新型コロナ効果有り論文撤回去れていますのでね。
イベルメクチン新型コロナ効果無し論文も出ていますのでね。
イベルメクチン新型コロナ効果無しと言う結論ですがね。
イベルメクチン新型コロナに効果有り論文は、間違った論文として撤回取り下げられていますのでね。
論文撤回取り下げと言うのは､論文が間違ったと言う事です。
新型コロナに効果無し論文も多く出ていますのでね。
Frontiers Removes Controversial Ivermectin Paper Pre-Publication
A review article containing contested claims about the tropical medicine drug as a COVID-19 treatment was listed as "provisionally accepted" on the jou...
The Scientist Magazine®
Retracted: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
Abstract. Ivermectin is an antiparasitic drug being investigated for repurposing against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Iver
OUP Academic
Large Ivermectin Study Retracted
Preprint publisher finds evidence of plagiarism, problems with raw data
New study shows ivermectin lacks meaningful benefits in COVID-19 treatment — Nuffield Department of Primary Care Health Sciences, University of Oxford
At a Higher Dose and Longer Duration, Ivermectin Still Not Effective Against COVID-19
A Cochrane meta-analysis of 11 eligible trials examining the efficacy of ivermectin for the treatment of COVID-19 published through April 2022 concluded that ive...
News: Ivermectin Has Little Effect on... (The New York Times) - Behind the headlines - NLM
(The New York Times) Ivermectin Has Little Effect on Recovery Time From Covid, Study Finds. Associated research findings from the National Library of Medicine.
NCBI
News: A large study finds that ivermectin... (The New York Times) - Behind the headlines - NLM
(The New York Times) A large study finds that ivermectin does not reduce risk of Covid-19 hospitalization.. Associated research findings from the National Librar...
NCBI
Ivermectin and COVID-19
The FDA has not authorized or approved ivermectin for use in preventing or treating COVID-19 in humans or animals.
U.S. Food and Drug Administration
Study supports evidence ivermectin not effective to treat COVID-19 — MORU Tropical Health Network
Yet another study shows little benefit for ivermectin with COVID-19
The observed median time to first recovery was 14 days in the ivermectin group and 15 in the usual-care group.
